High risk individuals in COVID-19 pandemic; an updated review

被引:2
作者
Chegini, Rojin [1 ]
Bolurian, Alireza [2 ,3 ]
Mojtahedi, Zahra [4 ]
Hafizi, Masoud [5 ]
机构
[1] Isfahan Univ Med Sci, Esfahan, Iran
[2] Oregon State Univ, Coll Pharm, Corvallis, OR 97331 USA
[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[4] Univ Nevada, Dept Hlth Care Adm & Policy, Sch Publ Hlth, Las Vegas, NV 89154 USA
[5] Shahrekord Univ Med Sci, Dept Infect Dis, Shahrekord, Iran
来源
IMMUNOPATHOLOGIA PERSA | 2021年 / 7卷 / 02期
关键词
COVID-19; SARSCov2; severity; COVID-19 risk factors; Diabetes; Obesity; Pregnancy; Cancer; Chronic renal failure; Angiotensin-converting enzyme 2;
D O I
10.34172/ipp.2021.25
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In December 2019, cases of pneumonia with an unknown pathogen were reporting in Wuhan city, China. The World Health Organization (WHO) recognized it as a pandemic, on March 11, 2020. The most frequent site of involvement is the respiratory system. The most common symptoms include cough, fatigue and fever. In some cases, neurological, respiratory and gastrointestinal complications can lead to death. Inflammatory cytokines can play a major role in pathogen damage. Due to the pandemic of COVID-19 and its severe complications, it is critical to identify the high-risk groups. Since this disease has a rapid transmission, following the instructions announced by the WHO, prevention is vital, especially in people with risk factors for disease complications and mortality. According to the latest reports by CDC (Center for Disease Control and Prevention), older age and having some medical conditions such as smoking, obesity (BMI >= 30 kg/m(2)), chronic obstructive pulmonary disease (COPD), heart disease, cancer, solid organ transplant, type 2 diabetes mellitus, chronic renal failure, and sickle cell anemia in younger adults are known disease severity risk factor.
引用
收藏
页数:5
相关论文
共 37 条
  • [1] Asthma and COVID-19
    Abrams, Elissa M.
    't Jong, Geert W.
    Yang, Connie L.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2020, 192 (20) : E551 - E551
  • [2] Role of vitamin D in preventing of COVID-19 infection, progression and severity
    Ali, Nurshad
    [J]. JOURNAL OF INFECTION AND PUBLIC HEALTH, 2020, 13 (10) : 1373 - 1380
  • [3] COVID-19 and Flu Pandemics Follow a Pattern: A Possible Cross-immunity in the Pandemic Origin and Graver Disease in Farther Regions
    Bolourian, Alireza
    Mojtahedi, Zahra
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2021, 52 (02) : 240 - 241
  • [4] Obesity and COVID-19: The mTOR pathway as a possible culprit
    Bolourian, Alireza
    Mojtahedi, Zahra
    [J]. OBESITY REVIEWS, 2020, 21 (09)
  • [5] Endocrine and metabolic link to coronavirus infection
    Bornstein, Stefan R.
    Dalan, Rinkoo
    Hopkins, David
    Mingrone, Geltrude
    Boehm, Bernhard O.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2020, 16 (06) : 297 - 298
  • [6] Coronavirus disease 2019 (COVID-19) pandemic and pregnancy
    Dashraath, Pradip
    Wong, Jing Lin Jeslyn
    Lim, Mei Xian Karen
    Lim, Li Mm
    Li, Sarah
    Biswas, Arijit
    Choolani, Mahesh
    Mattar, Citra
    Su, Lin Lin
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (06) : 521 - 531
  • [7] Gut microbiota and Covid-19-possible link and implications
    Dhar, Debojyoti
    Mohanty, Abhishek
    [J]. VIRUS RESEARCH, 2020, 285
  • [8] ElGohary Ghada M, 2022, Hematol Oncol Stem Cell Ther, V15, P45, DOI 10.1016/j.hemonc.2020.07.005
  • [9] CKD is a key risk factor for COVID-19 mortality
    Gansevoort, Ron T.
    Hilbrands, Luuk B.
    [J]. NATURE REVIEWS NEPHROLOGY, 2020, 16 (12) : 705 - 706
  • [10] Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19
    Gao, Yong
    Li, Tuantuan
    Han, Mingfeng
    Li, Xiuyong
    Wu, Dong
    Xu, Yuanhong
    Zhu, Yulin
    Liu, Yan
    Wang, Xiaowu
    Wang, Linding
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (07) : 791 - 796